|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 19.54 USD | +1.03% |
|
+0.31% | -35.87% |
| 08-12 | BofA Securities Adjusts Price Target on Beta Bionics to $18 From $15.50 | MT |
| 08-11 | BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 870M | - | ||||
| 234B | |||||
| 151B | |||||
| 131B | |||||
| 69.81B | |||||
| 52.33B |
- Stock Market
- Stocks
- BBNX Stock
- Charts Beta Bionics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
